Amarin Corporation PLC at Jefferies Healthcare Conference Transcript
All Right. Good morning, everyone. Well, thank you for joining us on this morning session here to kick off the 2023 Jefferies Global Healthcare Conference. I'm Michael Yee, Managing Director and one of the senior biotech analysts. Here with us up to kick off a session is Amarin, and up here with us is Aaron Berg, the Interim President and CEO, as well as Tom Reilly, the CFO, to join us for some fireside chats, Q&A, after some prepared remarks.
So with that, I'll turn it over to you and we'll have a discussion about Amarin.
Thanks, Michael. Appreciate it, and thanks to everyone for starting your day with us. So I'll give you a brief update. First of all, we'll be making forward-looking statements and there are inherent risks involved. I won't take the time to read through the disclaimer there that you're all familiar with.
So just in terms of our 2023 highlights, it's been -- it's hard to believe half the year is over with already. Quite
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
